Contribute
España
Italia
대한민국
日本
Français
Benzinga
Research
My Stocks
Tools
Free Benzinga Pro Trial
SPY
763.140.1%
QQQ
716.510.03%
BTC/USD
78188.000.1196%
DIA
524.880.15%
GLD
402.810.13%
TLT
81.680.06%

Praxis Precision Medicines Inc

PRAXNASDAQ
Trade with Public
Trade with Public
$345.30
-7.18-2.04%
At close: Sep 9, 5:00 PM EST
$344.75
-0.55-0.16%
After Hours: 7:06 PM EST
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentOwnershipCompareOptionsStock Report

Praxis Precision Medicine Analyst Price Targets

Wall Street analyst price targets and consensus rating for Praxis Precision Medicine (PRAX).

Price Target Range — 10 Quarters

Analyst Consensus — 17 Analysts

16Buy
1Sell
Consensus RatingBuy# Analysts17Avg. Consensus PT$539Upside to Avg. PT+56.2%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →
DateFirmAnalystActionRating ChangePrice Target
Aug 21, 2026Goldman SachsKevin StrangPT RaiseBuy$470→$575
Aug 7, 2026RBC CapitalLeonid TimashevPT RaiseOutperform$449→$462
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Goldman Sachs Maintains Buy on Praxis Precision Medicine, Raises Price Target to $575

Goldman Sachs analyst Kevin Strang maintains Praxis Precision Medicine (NASDAQ:PRAX) with a Buy and raises the price target from $470 to $575.
Benzinga Newsdesk

PRO
RBC Capital Maintains Outperform on Praxis Precision Medicine, Raises Price Target to $462

RBC Capital analyst Leonid Timashev maintains Praxis Precision Medicine (NASDAQ:PRAX) with a Outperform and raises the price target from $449 to $462.
Benzinga Newsdesk

PRO
Wells Fargo Maintains Equal-Weight on Praxis Precision Medicine, Raises Price Target to $362

Wells Fargo analyst Benjamin Burnett maintains Praxis Precision Medicine (NASDAQ:PRAX) with a Equal-Weight and raises the price target from $323 to $362.
Benzinga Newsdesk

PRO
Needham Maintains Buy on Praxis Precision Medicine, Raises Price Target to $582

Needham analyst Ami Fadia maintains Praxis Precision Medicine (NASDAQ:PRAX) with a Buy and raises the price target from $575 to $582.
Benzinga Newsdesk

PRO
BTIG Reiterates Buy on Praxis Precision Medicine, Maintains $810 Price Target

BTIG analyst Kambiz Yazdi reiterates Praxis Precision Medicine (NASDAQ:PRAX) with a Buy and maintains $810 price target.
Benzinga Newsdesk

PRO
Goldman Sachs Initiates Coverage On Praxis Precision Medicine with Buy Rating, Announces Price Target of $447

Goldman Sachs analyst Kevin Strang initiates coverage on Praxis Precision Medicine (NASDAQ:PRAX) with a Buy rating and announces Price Target of $447.
Benzinga Newsdesk

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved